Loncastuximab (RB4v1.2) 是一种抗 CD19 单克隆抗体 | MedChemExpress (MCE)

参考详情：Loncastuximab (RB4v1.2，朗妥昔单抗) - 仅供科研 | 抗CD19单抗 | MCE

CAS：1875032-68-0

品牌：MedChemExpress (MCE)

存储条件：Please store the product under the recommended conditions in the Certificate of Analysis.

生物活性：Loncastuximab (RB4v1.2) 是一种抗 CD19 单克隆抗体。Loncastuximab 展现出抗肿瘤性，在非霍奇金淋巴瘤 (NHL) 包括弥漫性大 B 细胞淋巴瘤 (DLBCL) 中也有潜在的应用。

热销产品：Lucifer Yellow CH (dipotassium salt)  | G140  | CX-5461  | SAR405  | Fostamatinib  | E 2012  | Sunvozertinib  | CRT0066101 (dihydrochloride)  | Birabresib  | BiP inducer X

研究领域：Immunology/Inflammation

作用靶点：CD19

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

参考文献：

[1]. Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190.

[2]. Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11.